Carcinoma, Hepatocellular

"Carcinoma, Hepatocellular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Descriptor ID	D006528
MeSH Number(s)	C04.557.470.200.025.255 C04.588.274.623.160 C06.301.623.160 C06.552.697.160
Concept/Terms	Carcinoma, Hepatocellular Carcinoma, Hepatocellular Carcinomas, Hepatocellular Hepatocellular Carcinomas Liver Cell Carcinoma, Adult Liver Cancer, Adult Adult Liver Cancer Adult Liver Cancers Cancer, Adult Liver Cancers, Adult Liver Liver Cancers, Adult Liver Cell Carcinoma Carcinoma, Liver Cell Carcinomas, Liver Cell Cell Carcinoma, Liver Cell Carcinomas, Liver Liver Cell Carcinomas Hepatocellular Carcinoma Hepatoma Hepatomas

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Hepatocellular".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]
Carcinoma, Hepatocellular [C04.557.470.200.025.255]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Liver Neoplasms [C04.588.274.623]
Carcinoma, Hepatocellular [C04.588.274.623.160]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Liver Neoplasms [C06.301.623]
Carcinoma, Hepatocellular [C06.301.623.160]
Liver Diseases [C06.552]
Liver Neoplasms [C06.552.697]
Carcinoma, Hepatocellular [C06.552.697.160]

Below are MeSH descriptors whose meaning is related to "Carcinoma, Hepatocellular".

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Hepatocellular".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Hepatocellular" by people in this website by year, and whether "Carcinoma, Hepatocellular" was a major or minor topic of these publications.

Bar chart showing 106 publications over 21 distinct years, with a maximum of 12 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	1	0	1
2001	0	1	1
2002	2	0	2
2003	3	2	5
2004	3	1	4
2005	4	1	5
2006	2	0	2
2008	1	1	2
2009	2	0	2
2010	4	1	5
2011	12	0	12
2012	4	0	4
2013	6	0	6
2014	5	0	5
2015	8	0	8
2016	10	1	11
2017	11	0	11
2018	10	0	10
2019	3	2	5
2020	3	0	3
2021	2	0	2

Below are the most recent publications written about "Carcinoma, Hepatocellular" by people in Profiles.

Daoud A, Soliman K, Teeter L, Ali H, Graviss EA, Mogawer S, Sholkamy A, El-Shazli M, Gaber AO. Alpha-Fetoprotein as a Modifier of Anatomic Criteria for Transplantation of HCC Patients. Transplant Proc. 2021 Apr; 53(3):833-838.

View in: PubMed
Yamada R, Gayed A. Adding Sorafenib-eluting Microspheres to TACE: The Next Step in Hepatocellular Carcinoma Treatment. Radiol Imaging Cancer. 2021 01; 3(1):e200132.

View in: PubMed
He G, Fu S, Li Y, Li T, Mei P, Feng L, Cai L, Cheng Y, Zhou C, Tang Y, Huang W, Liu H, Cen B, Pan M, Gao Y. TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients. Aging (Albany NY). 2020 11 11; 12(21):21544-21558.

View in: PubMed
Skanjeti A, Magand N, Defez D, Tordo J, Rode A, Manichon AF, Hallouard F, Clave-Darcissac C, Dhomps A, Townsend DM, Rubello D, Giammarile F. Selective internal radiation therapy of hepatic tumors: Morphologic and functional imaging for voxel-based computer-aided dosimetry. Biomed Pharmacother. 2020 Dec; 132:110865.

View in: PubMed
Hara Y, Yanatori I, Tanaka A, Kishi F, Lemasters JJ, Nishina S, Sasaki K, Hino K. Iron loss triggers mitophagy through induction of mitochondrial ferritin. EMBO Rep. 2020 11 05; 21(11):e50202.

View in: PubMed
Heslop KA, Rovini A, Hunt EG, Fang D, Morris ME, Christie CF, Gooz MB, DeHart DN, Dang Y, Lemasters JJ, Maldonado EN. JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells. Biochem Pharmacol. 2020 01; 171:113728.

View in: PubMed
Morrison M, Hughes HY, Naggie S, Syn WK. Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern? Dig Dis Sci. 2019 12; 64(12):3394-3401.

View in: PubMed
Norton PA, Mehta AS. Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review. World J Gastroenterol. 2019 Jun 21; 25(23):2947-2960.

View in: PubMed
Christie CF, Fang D, Hunt EG, Morris ME, Rovini A, Heslop KA, Beeson GC, Beeson CC, Maldonado EN. Statin-dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content. FASEB J. 2019 07; 33(7):8186-8201.

View in: PubMed
Tang B, Tian Y, Liao Y, Li Z, Yu S, Su H, Zhong F, Yuan G, Wang Y, Yu H, Tomlinson S, Qiu X, He S. CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma. Cell Death Dis. 2019 01 18; 10(2):52.

View in: PubMed

People

Explore

Similar Concepts

Top Journals